Matsuda Masahide 松田真秀

… Alternative Names

MATSUDA Masahide 松田真秀

Less

Researcher Number	30614333
Other IDs
Affiliation (Current)	2025: 筑波大学, 医学医療系, 准教授
Affiliation (based on the past Project Information) *help	2022 – 2024: 筑波大学, 医学医療系, 准教授 2014 – 2022: 筑波大学, 医学医療系, 講師 2012 – 2013: 筑波大学, 附属病院, 病院講師
Review Section/Research Field	Principal Investigator Basic Section 56010:Neurosurgery-related / Neurosurgery / Cerebral neurosurgery Except Principal Investigator Basic Section 56010:Neurosurgery-related / Neurosurgery
Keywords	Principal Investigator 不活化ウイルス粒子 / グリオーマ / 核酸医薬療法 / 光線力学療法 / 核酸療法 / miR-34a / 悪性髄膜腫 / glioma / 多角的免疫療法 / PD-L1 … More / 免疫チェックポイント / 制御性T細胞 / 脳腫瘍幹細胞 / microRNA / 新規免疫療法 / 脳腫瘍 / 自家腫瘍ワクチン … More Except Principal Investigator 悪性神経膠腫 / 免疫療法 / PD-L1 / 免疫チェックポイント分子 / グリオーマ / immunotherapy / glioma / ホウ素中性子捕捉療法 / 放射線療法 / 放射線力学的治療 / radiodynamic therapy / 蛍光力学療法 / 放射線力学療法 / iPS / 再発 / 血管新生 / 予後因子 / PI3Kγ阻害剤 / マクロファージ / 脳腫瘍学 / PD-1 / 神経膠腫 / 脳腫瘍 / glioma stem cell / immune checkpoint Less

Elucidation and Overcoming the Mechanism of Immune Cell Inactivation after Combination of Advanced Local Therapy and Immunotherapy for Glioblastoma
- Principal Investigator
  
  石川栄一
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  University of Tsukuba
光線力学と不活化ウイルスの連携によるグリオーマに対する革新的免疫療法Principal Investigator
- Principal Investigator
  
  松田真秀
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  University of Tsukuba
Combination therapy of radiodynamic therapy with porphyrin compounds and immunotherapy for glioma
- Principal Investigator
  
  石川栄一
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  University of Tsukuba
Development of novel oligonucleotide therapy for malignant meningioma using inactivated viral particlePrincipal Investigator
- Principal Investigator
  
  Matsuda Masahide
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  University of Tsukuba
Development of multifaceted immunotherapy for glioma using inactivated viral particlePrincipal Investigator
- Principal Investigator
  
  Matsuda Masahide
- Project Period (FY)
  2018 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  University of Tsukuba
Mechanism of immune cell inactivation using glioma stem cells and iPS cells
- Principal Investigator
  
  Ishikawa Eiichi
- Project Period (FY)
  2018 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56010:Neurosurgery-related
- Research Institution
  University of Tsukuba
Combination of Immune checkpoint inhibitors and vaccine in glioma stem cell
- Principal Investigator
  
  Ishikawa Eiichi
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Neurosurgery
- Research Institution
  University of Tsukuba
Development of novel nucleic acid therapy for brain tumor stem cells using inactivated viral particlePrincipal Investigator
- Principal Investigator
  
  MATSUDA MASAHIDE
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Neurosurgery
- Research Institution
  University of Tsukuba
Development of novel immunotherapy using combination of inactivated viral particle and autologous tumor vaccine for malignant gliomaPrincipal Investigator
- Principal Investigator
  
  MATSUDA Masahide
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Cerebral neurosurgery
- Research Institution
  University of Tsukuba

All 2024 2023 2022 2021 2020 2019 2018 2017 2014 2013 Other

All Journal Article Presentation

[Journal Article] High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis2023
- Author(s)
  Matsuda Masahide、Mizumoto Masashi、Kohzuki Hidehiro、Sugii Narushi、Sakurai Hideyuki、Ishikawa Eiichi
- Journal Title
  
  Radiation Oncology
  
  Volume: 18 Issue: 1 Pages: 38-38
- DOI
  10.1186/s13014-023-02236-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09170
[Journal Article] Timing of bevacizumab administration after biopsy for unresectable newly diagnosed glioblastoma2022
- Author(s)
  Matsuda Masahide、Kohzuki Hidehiro、Tsurubuchi Takao、Ishikawa Eiichi
- Journal Title
  
  Surgical Neurology International
  
  Volume: 13 Pages: 583-583
- DOI
  10.25259/sni_959_2022
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09170
[Journal Article] Hemagglutinating virus of Japan‐envelope containing programmed cell death‐ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma2020
- Author(s)
  Sugii Narushi、Matsuda Masahide、Okumura Genki、Shibuya Akira、Ishikawa Eiichi、Kaneda Yasufumi、Matsumura Akira
- Journal Title
  
  Cancer Science
  
  Volume: 112 Issue: 1 Pages: 81-90
- DOI
  10.1111/cas.14721
- NAID
  120007178959
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08988, KAKENHI-PROJECT-21H04836
[Journal Article] Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cells2020
- Author(s)
  Miyazaki Tsubasa、Ishikawa Eiichi、Matsuda Masahide、Sugii Narushi、Kohzuki Hedihiro、Akutsu Hiroyoshi、Sakamoto Noriaki、Takano Shingo、Matsumura Akira
- Journal Title
  
  Brain Tumor Pathology
  
  Volume: 37 Issue: 2 Pages: 41-49
- DOI
  10.1007/s10014-020-00357-z
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08962
[Journal Article] Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment2020
- Author(s)
  Miyazaki Tsubasa、Ishikawa Eiichi、Sugii Narushi、Matsuda Masahide
- Journal Title
  
  Cancers
  
  Volume: 12 Issue: 7 Pages: 1960-1960
- DOI
  10.3390/cancers12071960
- NAID
  120007180746
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08962
[Journal Article] Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome2017
- Author(s)
  Miyazaki Tsubasa、Ishikawa Eiichi、Matsuda Masahide、Akutsu Hiroyoshi、Osuka Satoru、Sakamoto Noriaki、Takano Shingo、Yamamoto Tetsuya、Tsuboi Koji、Matsumura Akira
- Journal Title
  
  Journal of Neuro-Oncology
  
  Volume: 133 Issue: 2 Pages: 277-285
- DOI
  10.1007/s11060-017-2451-7
- NAID
  120007128861
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15H04947, KAKENHI-PROJECT-16H05387, KAKENHI-PROJECT-15K10327, KAKENHI-PROJECT-16K15573
[Presentation] Hemagglutinating virus of Japan envelope を用いた髄膜腫に対する新規核酸療法の開発2024
- Author(s)
  石川隆昭、松田真秀、石川博、石川栄一
- Organizer
  第42回筑波脳神経外科研究会学術集会
- Data Source
  KAKENHI-PROJECT-21K09170
[Presentation] WHO grade 2 Oligodendroglioma 細胞株樹立2023
- Author(s)
  石川隆昭、松田真秀、石川博、石川栄一
- Organizer
  第41回日本ヒト細胞学会学術集会
- Data Source
  KAKENHI-PROJECT-21K09170
[Presentation] Hemagglutinating virus of Japan envelope による悪性髄膜腫に対する新規拡散療法の開発2023
- Author(s)
  石川隆昭、松田真秀、石川博、杉井成志、石川栄一
- Organizer
  第41回筑波脳神経外科研究会学術集会
- Data Source
  KAKENHI-PROJECT-21K09170
[Presentation] 患者由来髄膜腫細胞の低酸素培養による神経系細胞への誘導2022
- Author(s)
  石川隆昭、松田真秀、石川博、石川栄一
- Organizer
  第40回日本ヒト細胞学会学術集会
- Data Source
  KAKENHI-PROJECT-21K09170
[Presentation] PD-L1に対するsiRNAを封入したHVJ-Eはマウス神経膠腫に対し抗腫瘍免疫反応を惹起する2021
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一
- Organizer
  第39回日本脳腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 不活化センダイウイルス粒子と腫瘍PD-L1発現阻害は局所での免疫抑制を二重に解除し神経膠腫に対する抗腫瘍免疫を惹起する2020
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  日本脳神経外科学会第79回学術総会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 制御性Tリンパ球抑制と腫瘍PD-L1発現阻害の併用による悪性神経膠腫に対する免疫抑制的腫瘍微小環境の改善2019
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  第23回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 腫瘍PD-L1発現阻害と制御性Tリンパ球抑制の併用による新たな抗腫瘍免疫療法の開発2019
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  第37回日本脳腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 腫瘍PD-L1発現阻害と制御性Tリンパ球抑制の併用による悪性神経膠腫に対する新規抗腫瘍免疫療法の開発2019
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  第57回ニューロ・オンコロジィの会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 制御性Tリンパ球抑制と腫瘍PD-L1発現阻害の併用による悪性神経膠腫に対する新たな抗腫瘍免疫療法の開発2019
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  第20回日本分子脳神経外科学会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 腫瘍PD-L1発現阻害と制御性Ｔリンパ球抑制の併用による悪性神経膠腫に対する新たな抗腫瘍免疫療法の開発2019
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  第78回日本脳神経外科学会学術集会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 腫瘍 PD-L1 発現阻害と制御性Ｔリンパ球抑制の併用による新たな抗腫瘍免疫療法の開発2018
- Author(s)
  杉井成志、松田真秀、奥村元紀、渋谷彰、石川栄一、松村明
- Organizer
  第36回日本脳腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-18K08988
[Presentation] 再発膠芽腫におけるPD-1発現上昇と再発後の予後2017
- Author(s)
  5.石川栄一、松田真秀、宮崎　翼、高野晋吾、阿久津博義、松村　明
- Organizer
  第35回日本脳腫瘍学会
- Data Source
  KAKENHI-PROJECT-15K10327
[Presentation] 膠芽腫に対する腫瘍ワクチン療法の経過とPD-1抗体療法併用の可能性2017
- Author(s)
  7.石川栄一、松田真秀、宮崎　翼、阿久津博義、高野晋吾、松村　明
- Organizer
  第76回日本脳神経外科学会総会
- Data Source
  KAKENHI-PROJECT-15K10327
[Presentation] 悪性神経膠腫に対するnon-replicating oncolytic vector therapyの自家腫瘍ワクチンによる増強効果2014
- Author(s)
  小沼邦之、松田真秀
- Organizer
  第11回がんワクチン療法研究会学術集会
- Place of Presentation
  東京
- Year and Date
  2014-11-22
- Data Source
  KAKENHI-PROJECT-24791485
[Presentation] 悪性神経膠腫に対するnon-replicating oncolytic vector therapyの開発2013
- Author(s)
  松田　真秀
- Organizer
  第31回日本脳腫瘍学会学術集会
- Place of Presentation
  フェニックス・シーガイア・リゾート（宮崎県）
- Data Source
  KAKENHI-PROJECT-24791485
[Presentation] 悪性グリオーマに対する不活化ウイルス粒子と自家腫瘍ワクチンの併用療法
- Author(s)
  小沼邦之、松田真秀
- Organizer
  第32回日本脳腫瘍学会学術集会
- Place of Presentation
  千葉
- Year and Date
  2014-11-30 – 2014-12-02
- Data Source
  KAKENHI-PROJECT-24791485
[Presentation] Development of inactivated viral particle therapy for malignant glioma
- Author(s)
  Onuma K, Matsuda M
- Organizer
  11th Meeting of Asian Society for Neuro-Oncology
- Place of Presentation
  Istanbul,Turkey
- Year and Date
  2014-09-11 – 2014-09-14
- Data Source
  KAKENHI-PROJECT-24791485
[Presentation] 悪性グリオーマに対する不活化ウイルス粒子と自家腫瘍ワクチンの併用療法
- Author(s)
  小沼邦之、松田真秀
- Organizer
  日本脳神経外科学会第73回学術総会
- Place of Presentation
  東京
- Year and Date
  2014-10-09 – 2014-10-11
- Data Source
  KAKENHI-PROJECT-24791485

1. Ishikawa Eiichi (30510169)

# of Collaborated Projects: 5 results

# of Collaborated Products: 13 results
2. 松井裕史 (70272200)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
3. 坪井康次 (90188615)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. 石川博 (30089784)

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
5. 三木俊一郎 (10774036)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 鶴淵隆夫 (70778901)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. SUGII NARUSHI

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. TAKANO Shingo

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. MATSUDA Wakoto

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Matsuda Masahide 松田 真秀

MATSUDA Masahide 松田 真秀

Research Projects

Research Products

Co-Researchers

Elucidation and Overcoming the Mechanism of Immune Cell Inactivation after Combination of Advanced Local Therapy and Immunotherapy for Glioblastoma

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

光線力学と不活化ウイルスの連携によるグリオーマに対する革新的免疫療法Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Combination therapy of radiodynamic therapy with porphyrin compounds and immunotherapy for glioma

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of novel oligonucleotide therapy for malignant meningioma using inactivated viral particlePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of multifaceted immunotherapy for glioma using inactivated viral particlePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Mechanism of immune cell inactivation using glioma stem cells and iPS cells

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Combination of Immune checkpoint inhibitors and vaccine in glioma stem cell

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of novel nucleic acid therapy for brain tumor stem cells using inactivated viral particlePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of novel immunotherapy using combination of inactivated viral particle and autologous tumor vaccine for malignant gliomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Timing of bevacizumab administration after biopsy for unresectable newly diagnosed glioblastoma2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Hemagglutinating virus of Japan‐envelope containing programmed cell death‐ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma2020

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cells2020

Author(s)

Journal Title

DOI

Data Source

Matsuda Masahide 松田真秀

MATSUDA Masahide 松田真秀